[DOI] [PubMed] [Google Scholar] 31.Wilding J.P.H., Batterham R.L., Calanna S., Davies M., Van Gaal L.F., Lingvay I., et al
However, from Week 6 onward, p -values indicated no statistically significant difference between groups
Consistency in timing is important for maintaining steady drug levels in your body
For nausea Nausea is the most commonly reported side effect, particularly during dose increases 3
10.3748/wjg.v17.i36.4076 Summary Keywords nonalcoholic fatty liver disease, geniposide, therapeutic potential, mechanism, fatty liver disease Citation Zhang Q, Li Z and Wang L (2025) A potential herbal component for the future treatment of fatty liver disease: Geniposide from gardenia
The TRIUMPH-4 trial of retatrutide involved 445 participants with obesity and knee osteoarthritis, with 84% having a body mass index of 35 and over (the criteria for severe obesity)